S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q3 2025

RTW Investments

Period: Q3 2025 Β· Filed: 2025-11-14
View on SEC EDGAR β†—
AUM
$8.12B
Total portfolio value
Positions
74
Reported securities
Top Holding
MDGL
11.3% $914.4M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MDGLMADRIGAL PHARMACEUTICALS INC$914.4M11.27%$458.66$528.10+15.1%
11.3%
ARGXARGENX SE$496.7M6.12%$737.56$939.68+27.4%
6.1%
RNAMAVIDITY BIOSCIENCES INC$495.5M6.11%β€”β€”
6.1%
PTCTPTC THERAPEUTICS INC$475.4M5.86%$61.37$83.31+35.8%
5.9%
INSMINSMED INC$444.2M5.47%$144.01$111.60-22.5%
5.5%
PTGXPROTAGONIST THERAPEUTICS INC$382.4M4.71%$66.43$131.62+98.1%
4.7%
NTRANATERA INC$321.9M3.97%$160.97$279.32+73.5%
4.0%
AKROAKERO THERAPEUTICS INC$260.1M3.20%β€”β€”
3.2%
QUREUNIQURE NV$258.3M3.18%$58.37$41.81-28.4%
3.2%
PENPENUMBRA INC$219.5M2.70%$253.32$318.57+25.8%
2.7%
RDNTRADNET INC$214.6M2.64%$76.21$68.75-9.8%
2.6%
MRUSMERUS N V$190.7M2.35%β€”β€”
2.4%
TARSTARSUS PHARMACEUTICALS INC$188.8M2.33%$59.43$65.44+10.1%
2.3%
SYKSTRYKER CORPORATION$181.1M2.23%$366.78$326.54-11.0%
2.2%
IMCRIMMUNOCORE HLDGS PLC$176.9M2.18%$36.33$32.50-10.5%
2.2%
ACADACADIA PHARMACEUTICALS INC$152.5M1.88%$21.34$25.97+21.7%
1.9%
CYTKCYTOKINETICS INC$149.6M1.84%$54.96$86.49+57.4%
1.8%
NBIXNEUROCRINE BIOSCIENCES INC$149.1M1.84%$140.38$174.26+24.1%
1.8%
AXSMAXSOME THERAPEUTICS INC$135.9M1.67%$121.45$244.31+101.2%
1.7%
STOKSTOKE THERAPEUTICS INC$120.4M1.48%$23.50$32.70+39.1%
1.5%
APGEAPOGEE THERAPEUTICS INC$107.8M1.33%$39.73$132.91+234.5%
1.3%
ESTAESTABLISHMENT LABS HLDGS INC$106.1M1.31%$40.99$89.25+117.7%
1.3%
MASIMASIMO CORP$100.8M1.24%$147.55β€”
1.2%
RAREULTRAGENYX PHARMACEUTICAL IN$98.0M1.21%$30.08$33.47+11.3%
1.2%
GHGUARDANT HEALTH INC$92.5M1.14%$62.48$167.98+168.8%
1.1%
URGNUROGEN PHARMA LTD$90.7M1.12%$19.95$38.02+90.6%
1.1%
ISRGINTUITIVE SURGICAL INC$90.5M1.12%$447.23$426.01-4.7%
1.1%
GHRSGH RESEARCH PLC$79.6M0.98%$14.30$27.01+88.9%
1.0%
TSHATAYSHA GENE THERAPIES INC$79.6M0.98%$3.27$6.53+99.7%
1.0%
ZLABZAI LAB LTD$77.7M0.96%$33.89$19.12-43.6%
1.0%

Quarter-on-Quarter Activity

Q3 2025 vs. Q2 2025

New Positions (8)

TickerIssuerNotional
COGTCOGENT BIOSCIENCES INC$49.8M
AQSTAQUESTIVE THERAPEUTICS INC$34.9M
ABVXABIVAX SA$29.7M
BLTEBELITE BIO INC$23.1M
ALECALECTOR INC$20.7M
HTFLHEARTFLOW INC$16.7M
LRMRLARIMAR THERAPEUTICS INC$10.1M
CMPXCOMPASS THERAPEUTICS INC$8.8M

Exited Positions (8)

TickerIssuerNotional
VRNAVERONA PHARMA PLC$288.6M
ABTABBOTT LABS$60.4M
SLNOSOLENO THERAPEUTICS INC$35.6M
MLTXMOONLAKE IMMUNOTHERAPEUTICS$35.0M
ETNB89BIO INC$19.3M
CRGXCARGO THERAPEUTICS INC$5.0M
KMTSKESTRA MED TECHNOLOGIES LTD$3.3M
CBLLCERIBELL INC$2.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
REPLREPLIMUNE GROUP INC$7.6M+209.7%
XNCRXENCOR INC$54.1M+158.9%
RAREULTRAGENYX PHARMACEUTICAL IN$35.9M+90.8%+11.3%
CRNXCRINETICS PHARMACEUTICALS IN$22.9M+86.8%
GHGUARDANT HEALTH INC$48.0M+72.9%+168.8%
DYNDYNE THERAPEUTICS INC$20.5M+71.0%
CNTACENTESSA PHARMACEUTICALS PLC$35.5M+49.8%
VSTMVERASTEM INC$30.3M+27.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ALKSALKERMES PLC$-83.8M-64.3%
ZLABZAI LAB LTD$-116.0M-58.6%-43.6%
DGXQUEST DIAGNOSTICS INC$-42.2M-50.0%
TEMTEMPUS AI INC$-9.3M-50.0%
MRUSMERUS N V$-19.8M-49.4%
GEHCGE HEALTHCARE TECHNOLOGIES I$-16.8M-37.1%
AXSMAXSOME THERAPEUTICS INC$-22.5M-26.2%+101.2%
NTRANATERA INC$-116.2M-22.9%+73.5%
← Back to Hedge Funds